For the past few years, FDA has attempted to re-approve all the old drugs that made it to market before the current regulatory framework was in place. In an effort to catch up, the Wall Street Journal says, the regulatory body has been offering three years of market exclusivity to any company willing to do the clinical work and affirm the older drugs' efficacy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.